You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百濟神州(06160.HK):旗下產品於中國供應暫時中斷
阿思達克 03-26 09:25
百濟神州(06160.HK)公布,於今年3月25日(美國東部時間)獲悉國家藥品監督管理局宣佈暫停進口、銷售和使用美國新基公司(現隸屬百時美施貴寶)ABRAXANE注射用紫杉醇(白蛋白結合型)產品的決定。此項決定是基於對百時美施貴寶一家位於美國的合同生產機構的核查結果做出的。百濟神州預計這將造成ABRAXANE在中國的供應暫時中斷。

公司正在與百時美施貴寶密切合作以儘快恢復供應,包括百時美施貴寶對現有生產基地的整改工作以及遞交用其另一家生產工廠為中國供應的申請。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account